openPR Logo
Press release

Soaring Geriatric Demographic & Sophisticated Technology Buttress Geriatric Medicines Market; Fewer Geriatricians Dip the growth

Soaring Geriatric Demographic & Sophisticated Technology

Governments’ relentless pitch for all-round assistance for geriatric people along with technological advancements aimed at ameliorating medical assistance has underpinned the geriatric medicines market. One of the insurance programs in the United States named as the Federal Long Term Care Insurance Program has aptly incorporated near-to-full medical cost of the Americans. Factors such as longer life-expectancy, aging demographic, swelled awareness and adoption of sophisticated therapeutics are prophesized to propel the geriatric medicines market. These insights are in line with the report titled, “Geriatric Medicines Market—Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026,” which has been lately incorporated in the repository of Market Research Hub (MRH). In terms of revenue, geriatric medicines market is anticipated to register CAGR of over 6% during the assessment period.

Spreading hospital base coupled with soaring footprints for chronic disorders treatment are expected to fuel the demand for geriatric medicines. Further, ever increasing obese demographic prone to chronic diseases is set to spur the market during the assessment period.

Request for sample copy of this report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=207169

On the backdrop of sophisticated healthcare technologies and greater purchasing power, North America reigns the geriatric medicines market. Long Term Care Ombudsman Program (LTCOP) dispenses residential care facilities, nursing homes and assisted living facilities which has underpinned geriatric medicines market. In addition, rigorous research and development activities for build-out of new therapies have bolstered market for geriatric medicines. On the other hand, owing to escalating government support and thriving healthcare infrastructure, Asia Pacific is projected to witness a robust expansion of geriatric medicines market.

However, likely chances of harmful drug reaction coupled with fewer geriatricians are some of the roadblocks in the growth of geriatric medicines market. Besides, less number of patient participation in clinical trials further hamper the market.

Geriatric Medicines Market: Report Content

The report elucidates a comprehensive analysis of the geriatric medicines market delineating qualitative and quantitative assessment of the market. The report incorporates drivers, opportunities, restraints and trends shaping dynamics of the market. Further, the report segregates the geriatric medicines market to provide readers with insights to assist them in making assessment of the market. The report segments market on the basis of therapeutic category, condition, distribution channel and region.

Browse Full Report with TOC@@ https://www.marketresearchhub.com/report/geriatric-medicine-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019-report.html

The final section includes the competitive landscape to provide a dashboard view incorporating financial overview, company profile and product portfolio, SWOT analysis and strategies. Some of the prominent players delineated in the report are Merck & Co., Abbott Laboratories, Novartis and Pfizer, to name a few.

Geriatric Medicines Market: Research Methodology

The report provides research methodology incorporating secondary and primary research. The analysis in the report is on account of secondary research, primary interviews and reviews by expert panel. The report has been prepared on the basis of absolute dollar analysis which has often been overlooked. Growth rates delineated in the report are the result of rigorous assessment of demographics, past trends, future trends, regulatory requirements and technological advancements.

The secondary research include trade journals, stock analysis presentation, financial reports, SEC filings, company websites, Factiva, statistical database and industry white paper. Besides, it also incorporates national government documents, press releases, news articles and internal & external proprietary databases. The primary research incorporate surveys, e-mail interaction, interviews analysis of seasoned analyst, trade associations and phonic interviews.  To provide the readers with an honest report, expert panel assesses the data collated from different sources. 

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like Pharmaceutical market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us         

90 State Street,

Albany, NY 12207,

United States

Toll Free: 800-998-4852 (US-Canada)

Email: press@marketresearchhub.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Soaring Geriatric Demographic & Sophisticated Technology Buttress Geriatric Medicines Market; Fewer Geriatricians Dip the growth here

News-ID: 1493303 • Views:

More Releases from Market Research Hub - Pharmaceutical Industry

Global Enthesopathy Treatment Market Analysis by Type, Application, Top Key Players are-Abbott Laboratories, Eli Lilly, Janssen Biotech, Pfizer, Siemens and Forecast 2019-2025
Global Enthesopathy Treatment Market Analysis by Type, Application, Top Key Play …
The global market status for Enthesopathy Treatment is precisely examined through a smart research report added to the broad database managed by Market Research Hub (MRH). This study is titled “Global Enthesopathy Treatment Market Size, Status and Forecast 2019-2025”, which tends to deliver in-depth knowledge associated to the Enthesopathy Treatment market for the present and forecasted period until 2025. Furthermore, the report examines the target market based on market size,
Global BioImaging Technologies Market Status, Growth Opportunity, Scope, Key Players:-Hologic, Hitachi, Digirad, FONAR, Covidien, Mindray and Forecast 2019-2025
Global BioImaging Technologies Market Status, Growth Opportunity, Scope, Key Pla …
The market for BioImaging Technologies is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Global BioImaging Technologies Market Size, Status and Forecast 2019-2025” which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions. Furthermore,
Global Drugs and Diagnostics for Hematological Disorders Market Report Overview 2019-2025 | Top Players are-Abbot, Pfizer, Mindray, Roche, Biorad, Siemens
Global Drugs and Diagnostics for Hematological Disorders Market Report Overview …
Market Research Hub (MRH) has actively included a new research study titled “Global Drugs and Diagnostics for Hematological Disorders Market Size, Status and Forecast 2019-2025” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period
Global Biosimilar Testing and Development Services Market Report Overview 2019-2025 | Top Players are-Eurofins Scientific, Exova, Source BioScience, Intertek Group, Sigma-Aldrich
Global Biosimilar Testing and Development Services Market Report Overview 2019-2 …
Market Research Hub (MRH) has actively included a new research study titled “Global Biosimilar Testing and Development Services Market Size, Status and Forecast 2019-2025” to its wide online repository. The concerned market is discoursed based on a variety of market influential factors such as drivers, opportunities and restraints. This study tends to inform the readers about the current as well as future market scenarios extending up to the period until

All 5 Releases


More Releases for Geriatric

Cataract Market Geriatric & Future Scenario 2025
Global Cataract Market: Snapshot The incrementing demand in the global cataract market is a reflection of growing geriatric population, as people aged over 60 years frequently develop conditions wherein eyes have reduced elasticity and in turn affects the normal functioning. The market for cataract is also expected to gain from awareness programs such as VISION 2020, launched by the WHO and the International Agency for the Prevention of Blindness. Request Sample Copy
Global Geriatric Drugs and Disease Management Market: High Incidence of Chronic …
Researchmoz added Most up-to-date research on "Global Geriatric Drugs and Disease Management Market: High Incidence of Chronic Ailments among Geriatric Population Crea" to its huge collection of research reports. Geriatric medicine refers to a branch of medicine dealing with the diagnosis, treatment and prevention of diseases in the elderly population. Increasing demand for geriatric care medication and services is attributed to increasing needs of the elderly population. The geriatric population suffers
Geriatric Medicines Market Analysis & Trends 2023
The global market for geriatric medicines stood at US$ 504.7 bn in 2014 and is projected to expand at a CAGR of 7.3 % during 2015–2023. Rising at this pace, the opportunities in the market is anticipated to reach US$ 948.0 bn by the end of 2023. Governments’ Push for Quality Geriatric Care Bodes Well for Market The global geriatric medicines market is primarily driven the general rise in the elderly populations
Consistent Rise in Geriatric Population is Expected to Stimulate the Growth of G …
Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions. Complementary and alternative medicines include products such as dietary medicine
Consistent Rise in Geriatric Population is Expected to Stimulate Geriatric Compl …
Geriatric Complementary and Alternative Medicines (CAM) Market: Overview Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions. Browse to unlock
03-25-2017 | Health & Medicine
TMR
Consistent Rise in Geriatric Population is Expected to Stimulate the Growth of G …
Geriatric population is more susceptible to chronic diseases such as heart problems, joint disorders and others. Therefore, this population group needs regular use of the medicines to prevent the disease conditions. The use of complementary and alternative medicines is increasing among the geriatric population globally due to the fact that CAMs decreases the risk of adverse reactions and drug interactions. Complementary and alternative medicines include products such as dietary medicine